Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice

REFERENCES

• Charbeneau RP, Peters-Golden M: Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin Sci. 2005;108:479–491.
   PubMed Web of Science ®Google Scholar
• Perng DW, Wu YC, Chang KT, Wu MT, Chiou YC, Su KC, Perng RP, Lee YC: Leukotriene C4 induces TGF-β1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol. 2006;34:101–107.
   PubMed Web of Science ®Google Scholar
• Bossé Y, Thompson C, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M: Leukotriene D4-induced, epithelial cell-derived transforming growth factor β1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy. 2008;38:113–121.
   PubMed Web of Science ®Google Scholar
• Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M: Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1996;97:1827–1836.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogura T: Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1992;145:85–91.
   PubMed Web of Science ®Google Scholar
• Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, Moore BB: Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med. 2002;165:229–235.
   PubMed Web of Science ®Google Scholar
• Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y: Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci U S A. 2004;101:3047–3052.
   PubMed Web of Science ®Google Scholar
• Failla M, Genovese T, Mazzon E, Gili E, Muià C, Sortino M, Crimi N, Caputi AP, Cuzzocrea S, Vancheri C: Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res. 2006;7:137–149.
   PubMed Web of Science ®Google Scholar
• Izumo T, Kondo M, Nagai A: Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice. Life Sci. 2007;80:1882–1886.
   PubMed Web of Science ®Google Scholar
• Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS: Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol. 2005;167:1267–1277.
   PubMed Web of Science ®Google Scholar
• Moore BB, Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L152–L160.
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Munakata M, Ukita H, Takahashi T, Satoh A, Homma Y, Kawakami Y: Increased susceptibility to silicosis and TNF-α production in C57BL/6J mice. Am J Respir Crit Care Med. 1995;152:2144–2149.
   PubMed Web of Science ®Google Scholar
• Fujita M, Shannon JM, Morikawa O, Gauldie J, Hara N, Mason RJ: Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001;280:L39–L49.
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson JM, Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;42:467–470.
   Google Scholar
• Shiota N, Shimoura K, Okunishi H: Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast. Eur J Pharmacol. 2006;548:158–166.
   PubMed Web of Science ®Google Scholar
• Vannella KM, McMillan TR, Charbeneau RP, Wilke CA, Thomas PE, Toews GB, Peters-Golden M, Moore BB: Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J Immunol. 2007;179:7883–7890.
   PubMed Web of Science ®Google Scholar
• Dubois CM, Bissonnette E, Rola-Pleszczynski M: Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4. Am Rev Respir Dis. 1989;139:1257–1264.
   PubMed Web of Science ®Google Scholar
• Koren HS, Joyce M, Devlin RB, Becker S, Driscoll K, Madden MC: Modulation of eicosanoid production by human alveolar macrophages exposed to silica in vitro. Environ Health Perspect. 1992;97:77–83.
   PubMed Web of Science ®Google Scholar
• Crooks SW, Stockley RA: Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173–178.
   PubMed Web of Science ®Google Scholar
• Sala A, Zarini S, Folco G, Murphy RC, Henson PM: Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils. J Biol Chem. 1999;274:28264–28269.
   PubMed Web of Science ®Google Scholar
• James AJ, Penrose JF, Cazaly AM, Holgate ST, Sampson AP: Human bronchial fibroblasts express the 5-lipoxygenase pathway. Respir Res. 2006;7:102–112.
   PubMed Web of Science ®Google Scholar
• Cott GR, Westcott JY, Voelkel NF: Prostaglandin and leukotriene production by alveolar type II cells in vitro. Am J Physiol. 1990;258:L179–L187.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN: Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol. 1993;150:4188–4196.
   PubMed Web of Science ®Google Scholar
• Sullivan DE, Ferris M, Pociask D, Brody AR: Tumor necrosis factor-α induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol. 2005;32:342–349.
   PubMed Web of Science ®Google Scholar
• Ménard G, Bissonnette EY: Priming of alveolar macrophages by leukotriene D4: potentiation of inflammation. Am J Respir Cell Mol Biol. 2000;23:572–577.
   PubMed Web of Science ®Google Scholar
• Shim YM, Zhu Z, Zheng T, Lee CG, Homer RJ, Ma B, Elias JA: Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling. J Immunol. 2006;177:1918–1924.
   PubMed Web of Science ®Google Scholar
• Asakura T, Ishii Y, Chibana K, Fukuda T: Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-β. J Allergy Clin Immunol. 2004;114:310–315.
   PubMed Web of Science ®Google Scholar
• Sjöström M, Johansson AS, Schröder O, Qiu H, Palmblad J, Haeggström JZ: Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:e37–e41.
   PubMed Web of Science ®Google Scholar
• Yudina Y, Parhamifar L, Bengtsson AM, Juhas M, Sjölander A: Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells. Prostaglandins Leukot Essent Fatty Acids. 2008;79:223–231.
   PubMed Web of Science ®Google Scholar
• Espinosa K, Bossé Y, Stankova J, Rola-Pleszczynski M: CysLT1 receptor upregulation by TGF-β and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol. 2003;111:1032–1040.
   PubMed Web of Science ®Google Scholar